S&P 500 Slides to 7,691 on 5.31% Long Bond as Moderna Doubles and Target Beats by 75%
Nasdaq lost 1.33% to 26,289.71 with memory names down 7% to 9% | That's TradingNEWS
Key Points
- S&P 500 closed at 7,691.76, down 0.69%, its third straight loss and 124.94 points off the record.
- Moderna hit $125.68 premarket, up 99% from $62.96, after the Phase 3 melanoma readout with Merck.
- Target posted EPS of $4.11 versus $2.34 expected on 3.8% comps, yet fell 3.5% to $147.15.
The S&P 500 (SPX) closed Tuesday at 7,691.76, down 0.69%, a third consecutive losing session and a full 124.94 points below the 7,816.70 intraday record printed on August 13. The Nasdaq Composite (IXIC) got smoked harder, dropping 1.33% to 26,289.71. The Dow Jones Industrial Average (DJI) held up best of the three, shedding 116.38 points, or 0.22%, to 53,343.40. The Russell 2000 gave back 0.35%. Volume on the S&P ran roughly 972.5 million shares against a much larger average, and 55.7% of all U.S. issues finished lower.
Set that against the earnings backdrop and the disconnect is the whole story. Second-quarter S&P 500 profits are tracking a 50% year-over-year increase — the fastest growth rate since 2021. Companies are printing the best aggregate numbers in five years and the index has lost ground for three straight sessions. That gap is not an earnings problem. It is a discount-rate problem.
The 30-year Treasury yield scored a fresh 19-year high Tuesday after clearing 5.311% on Monday, the highest since June 2007. The 10-year pushed toward 4.75%, a 20-month peak. Every multiple in the market is being repriced against those two numbers, and the repricing is landing hardest on the longest-duration assets — semiconductors, software, anything valued on 2030 cash flows.
Wednesday's setup flipped green before the bell. S&P futures (ES) traded 7,748.75, up 34.75 points or 0.45%. Dow futures added 283 points to 53,686, a 0.53% gain. Nasdaq-100 futures rose 157.75 to 29,743.75, also up 0.53%. Russell 2000 futures outperformed at 3,051.50, up 0.83%. The VIX faded 2.53% to 15.44 after climbing 3.75% Tuesday off its 2026 lows. Gold ripped 1.70% to $4,495.60. Crude eased 0.17% to $83.92. Bitcoin added 1.03% to $64,821.82.
Two events decide where the close lands: the July FOMC minutes at 2:00 p.m. ET and a 20-year Treasury auction that will test whether anyone still wants duration at these levels. Five of the previous seven 20-year auctions tailed. A sixth tail inside a week when the long bond already sits at 5.3% would put the August 13 record back out of reach for a while.
The 30-Year at 5.31% Is Running Everything Else
The long end is not drifting. It is repricing, and the mechanics are specific. The Treasury sold $25 billion of new 30-year bonds last week at 5.216% — the highest yield for that auction since 2001. The 10-year auction the day before drew the steepest financing cost since 2007. The 30-year rate then advanced more than four basis points to 5.311% on Monday and pushed to a fresh 19-year high Tuesday, closing in on the 5.44% peak from the early days of the financial crisis.
What makes this move different is that it happened into softening data. July CPI came in line. PPI was unchanged. Employers unexpectedly cut jobs in July. Retail sales fell by the most in more than a year. Any one of those prints would normally pull yields lower. Instead the curve steepened — front end richening, long end cheapening — because the bid is disappearing from the part of the curve that requires a view on the next twenty years of American fiscal policy.
Three pressures are stacked. Federal deficit spending is projected at $2.1 trillion this year against a national debt closing on $40 trillion. Corporate supply is competing directly for the same capital, with AI-related issuance estimated at as much as $1.5 trillion in 2026 alone. And inflation has been parked above the Fed's 2% target for five straight years, with CPI running 3.4% year over year in July.
Foreign demand is thinning at the same time. Treasury data released Monday showed the U.K., China and Japan all cut their holdings in June. That is the top three holders reducing in the same month the long bond broke out.
The 10-year sat at 4.70% Wednesday morning, down 0.21% on the session, which gave equities their bid. The 10-2 spread widened 15.27% to 31.32 basis points. Fundstrat's technical read puts long-term yields on a path toward 5.60%–5.70% following the resolution of a three-year triangle pattern. If that plays out, the 5.44% crisis-era high is a waypoint, not a ceiling — and the equity multiple math changes materially at those levels.
Global confirmation is everywhere. Japan's 10-year hit 2.95%, the highest since 1996. Germany's 30-year bund reached its highest since 2011. France's 30-year touched levels last seen in 2008.
Memory Got Smoked and Took the Nasdaq Down With It
The semiconductor unwind Tuesday was concentrated and violent, and it was concentrated specifically in memory. Western Digital fell 7%. Sandisk dropped 9%. Seagate Technology lost more than 9%. Marvell Technology gave up nearly 8%. Those four names alone did most of the damage to the Nasdaq's 1.33% decline, with the index closing at 26,289.71 after a 355-point drop from Monday's 26,644.91.
The setup makes the reversal sharper. Memory had been the strongest subsector on the tape. Micron finished Thursday, August 13 up 4% at $949.83 after NewStreet Research upgraded it to buy with a $1,250 twelve-month target built on an EV/COGS framework against 2028 and 2030 cost estimates. On Monday, semis, memory, AI infrastructure and thematic favorites including quantum and robotics were among the best performers on the board while hyperscalers and software lagged. Twenty-four hours later the entire complex reversed.
Nvidia closed Tuesday at $219.74, down 2.34%. Caterpillar led the Dow lower at -2.86%. Home Depot slipped 1.24% despite results that impressed on the print. Offsetting bids came from Johnson & Johnson at +2.29%, IBM at +1.43% and Chevron at +1.41% — a defensive, cash-flow-now rotation inside a single index.
Healthcare and biotechnology climbed to all-time highs Tuesday while chips bled. Johnson & Johnson rose more than 3% in afternoon trade heading for its first record close since July 7, when it gained 3.1% to $267.24. The stock has gained roughly 31% year to date, more than double the S&P 500's advance over the same stretch.
Software found a bid on the same day semis broke. Intuit rose more than 4% to lead Nasdaq 100 gainers and Adobe advanced more than 3%. Fabrinet cratered more than 19% despite strong fiscal Q4 results and Q1 guidance, as concerns about specific business segments overwhelmed the beat. Klarna dropped more than 22% after cutting full-year revenue guidance and announcing the abrupt departures of its CFO and CMO.
Micron traded up 2.5% to $963.90 in Wednesday's premarket, an attempt at stabilization rather than a reversal. Nvidia reports August 26, which now functions as the next hard test of whether AI capex spending survives contact with 5.3% long-end funding costs.
Asia Cracked Overnight and the Damage Was Structural
The overnight tape out of Asia was the worst single-session read of the week. Japan's Nikkei 225 fell 3.16%. South Korea's KOSPI dropped 5%. Those are not rotation moves. Those are forced-selling moves, and both trace back to the same source as the U.S. selloff — the long end of the sovereign curve.
Samsung Electronics fell 7.8% as the Korean yield shock deepened the semiconductor rout. The SK hynix ADR (SKHY) traded down 9.20% to $155.62. That happened on the same day SK hynix announced a treasury share buyback and cancellation program worth 40 trillion won, or $28.61 billion, alongside a commitment to spend at least 50% of free cash flow generated from 2025 through 2027 on shareholder returns. A capital return of that size is a statement about cash generation from AI-driven memory demand. The stock fell 9% anyway.
That is the cleanest illustration available of what the tape is currently pricing. Company-level cash flow is not the binding constraint. The cost of capital is. When a chipmaker announces a $28.6 billion buyback into the teeth of a bond selloff and gets sold nine points, the message is that duration risk outranks fundamentals until the long end stabilizes.
Japan's specific problem compounds it. The 10-year JGB at 2.95% is the highest since 1996, driven by expectations the Bank of Japan hikes as soon as September. Japanese Q2 GDP expanded at an annualized 1.1%, missing the 2% consensus and down from 2.1% the prior quarter — the first full quarter to absorb the energy-price impact of the Iran war. Weak growth, hot inflation, and a government that has not explained how it will fund a proposed two-year food sales tax cut.
Europe opened flat into that. The STOXX 600 sat at 652.07 as mining gains tracking gold offset a 0.4% decline in the technology index. Soitec dropped 4.4%. Nordic Semiconductor and Scout24 also declined. Higher rates pressured the growth complex while commodity exposure absorbed the hit — the identical split visible in New York.
Moderna Nearly Doubled Before the Bell on the First mRNA Cancer Win
Moderna (MRNA) closed Tuesday at $62.96. In Wednesday's premarket it hit $125.68 — up 99.6% — before settling into a range between $98.35 and $103.60, a gain of 56% to 90% depending on the print. Merck (MRK) closed at $135.17 and traded up to roughly $143.53, a gain of 6% to 8%.
The catalyst was the Phase 3 INTerpath-001 readout, announced jointly by Merck and Moderna. The trial enrolled 1,137 patients with completely resected stage IIB–IV cutaneous melanoma, randomized 2:1 to receive intismeran autogene — 1 mg every three weeks for up to nine doses — plus Keytruda, or Keytruda alone, for approximately one year. At a pre-planned interim analysis the combination delivered statistically significant improvements in recurrence-free survival, the primary endpoint, and distant metastasis-free survival, a key secondary endpoint. No new safety signals emerged. The study was stopped at first interim analysis.
This is the first positive Phase 3 result for an individualized neoantigen therapy and for any mRNA-based cancer treatment. Intismeran encodes as many as 34 neoantigens derived from mutations found in each patient's own tumor. No hazard ratios or p-values were disclosed in the topline release. Citi had flagged an RFS hazard ratio at or below 0.72 as positive, with 0.65 or lower representing a clear win. The Phase 2b KEYNOTE-942 five-year data presented at ASCO in 2026 showed a 49% reduction in risk of recurrence or death (HR 0.51) and a 59% reduction in distant metastasis or death (HR 0.411).
The size asymmetry explains the move differential. Merck carried a market cap around $333 billion entering Wednesday. Moderna sat near $25 billion. Barclays modeled roughly $3 billion in annual melanoma sales by 2035. William Blair upgraded Moderna to Outperform from Market Perform, citing a clear line of sight to revenue diversification away from COVID.
Google Finance listed 1 Buy, 12 Hold and 2 Sell among 15 analysts covering Moderna as of August 6. The $99.02 premarket indication at 07:25 ET cleared every published target. The INTerpath program now spans nine Phase 2 and Phase 3 trials across melanoma, non-small cell lung cancer, bladder cancer and renal cell carcinoma.
Target Beat Everything and the Stock Still Got Sold
Target (TGT) delivered the strongest quarter of its turnaround and fell 3.5% to $147.15 on the print. Second-quarter net sales reached $26.54 billion, up 5.3% year over year against a $26.15 billion consensus. Comparable sales grew 3.8%, crushing the 2.4% Street estimate, driven by a 3.6% increase in comparable traffic. Store comps rose 2.7%. Digital comps rose 8.7%, led by more than 25% growth in same-day delivery. Non-merchandise sales — Roundel advertising, Target Circle 360 and the Target Plus marketplace — grew 20.1%.
GAAP and adjusted diluted EPS came in at $4.11 against $2.05 a year earlier, a 75.8% beat versus the $2.34 consensus. That figure includes $994 million of pretax IEEPA tariff refund benefits recognized inside gross margin, contributing $752 million to net earnings, $1.65 to EPS, and 3.7 percentage points to the 9.6% operating margin. Strip the refunds and EPS still rose about 20%. Operating margin a year ago was 5.2%.
Target raised full-year guidance to net sales growth of about 5%, up a full percentage point, with operating margin around 6% including roughly 90 basis points from refunds. Full-year EPS guidance moved to $9.90–$10.90 including refunds, or $8.25–$9.25 excluding them, against a prior range of $7.50–$8.50. Trailing twelve-month ROIC improved to 15.4% from 14.3%. Capital expenditures rose 27% to $1.4 billion in the quarter. The company paid $518 million in dividends and repurchased no stock despite $8.3 billion remaining under authorization. Store count hit 2,019, up from 1,981.
All six core merchandising categories grew, with double-digit growth in Fun 101 and high single-digit growth in Food & Beverage and Beauty. Prices were lowered on more than 10,000 items over the past year.
The sell-off is a positioning story. Target entered the print up 52.8% year to date near two-year highs, trading above the $143.46 average target price. Options had priced a 7.08% move. The stock had already cleared what the Street would pay for a good quarter, so a great quarter with a one-time tariff refund doing $1.65 of the EPS lift was not enough to extend the run.
Lowe's Cut Guidance and the DIY Consumer Stayed Frozen
Lowe's (LOW) fell 2.9% to 3.3% premarket after cutting the top end off every full-year number. Second-quarter net earnings came in at $2.4 billion and diluted EPS of $4.27, flat against $4.27 in the year-ago quarter. Adjusted diluted EPS rose 1.6% to $4.40, excluding $96 million in pretax expenses tied to the Foundation Building Materials and Artisan Design Group acquisitions. Both EPS figures include an $0.11 benefit from IEEPA tariff refunds.
Total sales hit $26.0 billion against $24.0 billion a year earlier — an 8.3% increase built almost entirely on acquisitions. Revenue of $25.96 billion missed the $26.16 billion consensus. Comparable sales rose just 0.2% against 0.8% expected, marking a fifth consecutive quarter of positive comps but at a rate that rounds to nothing. Online sales grew 15.7%. Pro and home services carried the quarter; DIY stayed soft.
Full-year 2026 guidance now calls for total sales of $92.0 billion, the floor of the prior $92.0–$94.0 billion range. Comparable sales are projected flat, down from flat to up 2%. Operating margin guidance sits at 11.2%, adjusted at 11.6%. Diluted EPS is guided to about $11.75 and adjusted diluted EPS to about $12.25 — the bottom of the prior $12.25–$12.75 range. Second-quarter operating margin was 13.67%. Six-month operating cash flow reached $7.009 billion against $4.058 billion of financing outflows. The company operated 1,761 stores at July 31 and paid $673 million in dividends.
The read-through is direct. High mortgage rates and frozen housing turnover keep homeowners in their houses but stop them from committing to big-ticket renovation. Home Depot's Tuesday print said the same thing from the other side — sales improved as customers leaned toward smaller summer projects. July housing starts missed consensus while building permits rose 5% monthly to a seasonally adjusted annual 1.44 million, topping estimates.
Lowe's entered the print already damaged, closing at $223.35 on August 7, down about 13% on the year and roughly 24% below its 52-week high of $293.06. The forward EBITDA multiple around 12.7 times sits below TJX at 20.8 times and Ross Stores at 21.5 times. With comps guided flat and the long end at 5.3%, that discount is the market pricing the cycle, not offering a gift.
TJX Raised, Estée Lauder Popped, and the Barbell Held
The off-price and luxury ends of discretionary both worked while the middle struggled. TJX (TJX) lifted fiscal 2027 earnings guidance to $5.31–$5.36 per share from $5.08–$5.15, a raise of roughly 23 cents at the midpoint, while holding annual sales guidance steady. Cautious third-quarter guidance capped the reaction and weighed on the shares despite the full-year lift. TJX entered the print around $151–$153, carrying a $168 billion market cap and a price-to-earnings multiple near 29.6, with a 52-week range of $132.01 to $170.00. The median target across 22 covering analysts sits at $178.
The company operates more than 5,200 stores across ten countries under TJ Maxx, Marshalls, HomeGoods, Homesense and Sierra in the U.S., Winners and Marshalls in Canada, TK Maxx and Homesense in Europe, and TK Maxx in Australia. Merchandise runs 20% to 60% below full-price competitors. That model works precisely when the mid-market consumer trades down, which is exactly what Lowe's DIY softness and Target's value-driven traffic gains describe.
Estée Lauder (EL) rose nearly 8% premarket from a $84.27 base after forecasting fiscal 2027 adjusted earnings of $3.10 to $3.35 per share, with the midpoint above the $3.18 consensus. Fourth-quarter sales of $3.63 billion also beat. Luxury fragrance drove the outperformance — Le Labo and Tom Ford led 10% net sales growth. A $38 million cost-of-sales benefit from tariff refunds partly offset $102 million of tariff impact recorded across fiscal 2026.
The pattern across all four consumer prints is consistent. Value retail is taking share. Prestige fragrance is inelastic. Big-ticket home improvement is dead. General merchandise is recovering but priced for it. Consumers continued to spend through the quarter despite geopolitical pressure and elevated inflation, but they spent selectively and they spent down-market or at the very top.
Walmart reports Thursday before the open and now carries outsized weight. Placer.ai data showed Target store visits up 4.7% year over year in the second quarter against just 0.7% for Walmart. If Walmart confirms share loss to a resurgent Target, the consumer-staples leadership assumption underpinning a lot of defensive positioning gets tested at exactly the wrong moment.
Analog Devices Printed a Record and Guided Above Every Estimate
Analog Devices (ADI) delivered the cleanest semiconductor print of the week and rose 1% to 2% premarket from a $376.63 close. Fiscal third-quarter revenue hit a record $4.02 billion, up 40% from $2.88 billion a year ago and well above the $3.91 billion consensus. Growth was led by Data Center and Industrial.
GAAP diluted EPS jumped 163% to $2.74 from $1.04. Net income climbed to $1.34 billion from $518.5 million. Adjusted diluted EPS rose 68% to $3.45, beating the $3.34 estimate by 11 cents and clearing the company's own $3.30 guidance midpoint. GAAP gross margin reached 67.3% with operating margin at 40.1%. Adjusted gross margin hit 72.5% and adjusted operating margin 50.0% — versus the roughly 39% reported operating margin management had guided.
Trailing twelve-month operating cash flow reached $5.5 billion and free cash flow $4.9 billion, running at 40% and 36% of revenue. The company returned $1.7 billion to shareholders in the quarter through dividends and buybacks, and $5.2 billion over the trailing twelve months. The board declared a quarterly dividend of $1.10 per share, payable September 15 to holders of record September 1, extending a twenty-two-year streak of increases.
Fourth-quarter guidance is where the print separates itself. Revenue is forecast at $4.3 billion plus or minus $100 million against a $4.08 billion consensus. Reported operating margin is guided to approximately 42.6% and adjusted operating margin to approximately 52.0%. Reported EPS is guided to $3.14 plus or minus $0.15 and adjusted EPS to $3.86 plus or minus $0.15, against a $3.55 Street number. The guided range of $3.71 to $4.01 sits entirely above consensus.
The sequential progression tells the story: $3.16 billion in fiscal Q1, $3.62 billion in Q2, $4.02 billion in Q3, $4.3 billion guided for Q4. Industrial and Communications together accounted for 65% of Q2 revenue with year-over-year growth of 56% and 79%. Record bookings across Industrial, Automotive and Communications preceded this quarter, and management describes demand strengthening across every product line and region.
ADI carries a 52-week range of $223.47 to $445.91 against an average target near $441. A 40% revenue grower with a 52% adjusted operating margin should not need defending — unless the discount rate keeps climbing.
Read More
-
Lowe's Bought $1.95B of Growth and Delivered 0.2% Comps
19.08.2026 · TradingNEWS ArchiveStocks
-
XRP Sits 72% Below $3.65 After Winning Every Catalyst It Was Waiting For
19.08.2026 · TradingNEWS ArchiveCrypto
-
Brent Holds $91 With 8.3M Barrels a Day Still Shut In Behind Hormuz
19.08.2026 · TradingNEWS ArchiveCommodities
-
TLT ETF at $81.81 Yields 4.98% With 16 Years of Duration Against a 5.323% Long Bond
18.08.2026 · TradingNEWS ArchiveMarkets
-
Sterling Stuck Below 1.3570 as a 13% Energy Cap Hike Drives the Whole CPI Beat
19.08.2026 · TradingNEWS ArchiveForex
Trump Paused the Canada Tariffs at Midnight
The 50% tariffs on Canadian goods scheduled to take effect at midnight were paused for three days. The announcement came late Tuesday night via Truth Social, citing the finalization of documents and a completed deal, following eleventh-hour negotiations between administration officials and Prime Minister Mark Carney's team.
Futures barely reacted. Dow and S&P contracts hovered near flat immediately after the post, with Nasdaq-100 futures down 0.2%, before the broader risk-on bid developed later in the session. The muted response reflects two things: the direct economic ramifications of the Canadian tariffs were assessed as limited, and a three-day pause is not a resolution.
The signal matters more than the levy. The pause reads as positioning ahead of United States-Mexico-Canada Agreement renegotiation, which puts continental trade architecture back on the calendar as a live variable heading into midterms. A three-day extension buys time to paper a deal; it does not settle what the deal contains.
Tariff refunds are simultaneously distorting reported earnings across the entire retail complex. Target booked $994 million of IEEPA refunds inside gross margin, worth $1.65 of its $4.11 EPS and 3.7 points of its 9.6% operating margin. Lowe's booked $0.11 per share. Estée Lauder recognized a $38 million cost-of-sales benefit against $102 million of tariff impact across fiscal 2026. Every guidance figure issued this morning explicitly excludes any potential future refunds.
That creates a comparability problem heading into the back half. Target's full-year EPS guide spans $9.90–$10.90 including refunds and $8.25–$9.25 excluding them — a full dollar-sixty-five of spread that depends entirely on policy rather than operations. Anyone modeling 2027 off reported 2026 numbers is modeling a one-time legal outcome as a run rate.
TJX has been the structural beneficiary of tariff disruption rather than the refund mechanism. Supply-chain dislocation historically improves merchandise availability for off-price buyers, which is part of why the model raised guidance while Lowe's cut. The trade policy variable is not uniformly negative across retail — it redistributes.
The oil complex remains the dominant policy input regardless. The Canadian pause did nothing for the energy picture, and energy is what has been feeding the inflation expectations that broke the long end.
Oil Near $84, Brent at $91, and a Record Diesel Crack
Crude rose to its highest level in more than two weeks Tuesday after the administration signaled intent to inflict further economic pain on Iran and threatened to bomb Oman if it interferes with U.S. plans for the Strait of Hormuz. Brent traded near $91 per barrel. West Texas Intermediate reached $84 as the U.S. Strategic Petroleum Reserve plunged to its lowest level since 1982.
The 60-day ceasefire expired Monday with nothing replacing it. Iran shifted posture from defensive to fully offensive. Middle East shipping traffic remains a fraction of normal levels. Crude gained approximately 3% Monday alone, and energy was the only S&P 500 sector to finish higher that session as ten of eleven sectors fell.
Wednesday brought a modest fade — WTI at $83.92, down 0.17%, after trading as high as $84.78 earlier. The EIA weekly crude inventories report was due at 9:30 a.m. ET, with economists expecting a 0.2 million barrel figure against last week's 17.4 million.
The refining margin is where the real number sits. The U.S. diesel crack reached a record $102.20 per barrel on August 17. Valero closed Tuesday at $350.05, just 0.27% below its 52-week high, against an average analyst target of $320.67. The company's second-quarter adjusted refining operating income rose to $4.44 billion from $1.27 billion a year earlier, with operating cash flow of $5.6 billion. U.S. diesel cleared $5 per gallon in July.
That is the transmission mechanism into the bond market. Energy has already lifted underlying inflation this year, and BMO flagged energy as the primary bearish trigger for Treasuries given that yields have refused to fall despite softer economic data. A renewed commodity shock hits growth and inflation simultaneously — the combination Deutsche Bank warned could hit equities and bonds at the same time.
Gold ripped 1.70% to $4,495.60 Wednesday morning after touching $4,410.90 overnight, up more than 10% on the month. The metal has been bid by falling hike odds and the unresolved Hormuz standoff in equal measure. Bitcoin held $64,821.82, up 1.03%. Both are trading as term-premium hedges rather than risk assets.
The 2:00 PM Minutes: Three Dissents and 32.6% September Odds
The July 28–29 FOMC minutes hit at 2:00 p.m. ET. The committee held the federal funds rate at 3.50%–3.75% with a 9–3 vote, as regional presidents Logan, Hammack and Kashkari all dissented in favor of a 25 basis point hike — the first time since September 2016 that three policymakers aligned on a single directional dissent. The meeting calendar puts the release exactly three weeks after the decision.
The statement was nearly unchanged from June and offered no forward guidance, consistent with Chair Warsh's stated aversion to signaling the policy path. Economic activity was described as expanding at a solid pace, supported by strong productivity and capital investment alongside steady job gains. With written guidance withdrawn, every meeting is effectively live.
Markets initially read the July decision as dovish and unwound hawkish positioning. September hold expectations have since risen to roughly 65–67%. Rate futures currently price a 67.4% chance of no change and a 32.6% chance of a 25 basis point hike at the September 15–16 meeting, up from a near coin flip in recent weeks. Unemployment held at 4.1%. July inflation eased slightly.
The specific question is whether hawkish sentiment extended beyond the three dissenters. If the minutes reveal broader support for tightening, September hike odds reprice higher and the long end faces another leg. If the dissent looks isolated, the base case holds. Warsh also appeared comfortable with the recent tightening in financial conditions, suggesting the market has been doing some of the Fed's work — which raises the possibility of leaning on balance-sheet policy alongside the funds rate.
The calendar after this is dense. July PCE lands August 26. Jackson Hole runs August 27–29, where Warsh delivers his first keynote as chair. The September FOMC carries a fresh Summary of Economic Projections — the first dot plot since June, when the committee penciled in one quarter-point increase by year-end. Futures continue to price higher odds of a move at the October 27–28 and December 8–9 meetings than at September, which reads as a postponed hike rather than a cancelled one.
The 20-year auction settling August 31 is the other event, and it may matter more.
Breadth, Sectors, and What the Rotation Is Actually Saying
The month-to-date sector picture cuts against the narrative that this is a broad risk-off event. Six of eleven S&P 500 sectors are higher month to date. Technology leads with a gain of more than 7%. Communication services lags, down more than 1%. The Dow is on track for a fifth straight positive month while the S&P 500 and Nasdaq Composite are on pace for their first positive month in three.
Tuesday's internals show what is rotating and what is not. The equal-weight S&P hovered around unchanged while the cap-weighted index fell 0.69% — energy, staples and healthcare all up roughly 1.5%, small and midcap indices down about 1%. Monday told a similar story, with the equal-weight index down 0.8% against the cap-weighted 0.5%. That inversion between sessions is what makes the tape hard to trade: leadership is switching daily.
Retail thematic favorites have taken the worst of it — quantum, rare earths and robotics all under significant pressure ahead of the Unitree IPO in China. Nike sits at lows not seen since September 2014, down almost 39% on the year and off more than 4% in Tuesday midday trading as competition from On and other challengers compounds the damage.
The Russell 2000 touched all-time highs three times during the week ended August 14, which stands out against the current pullback. Small caps outperformed modestly Monday and Russell futures led Wednesday's premarket bid at +0.83%. Broadening breadth into a rate shock is not the normal pattern and argues the equity de-rating is targeted at duration rather than the economy.
Options expiration this week is a live variable. The S&P gapped down roughly 0.5% to about 7,700 Tuesday and then traded a tight 20-point range for the balance of the session, which reads as a gamma pin rather than genuine two-way flow. That pin releases Friday.
The iShares 20+ Year Treasury Bond ETF (TLT) sits near its lowest point in fund history after soaring to all-time highs during the zero-rate era — the single cleanest chart of what has happened to duration since 2020, and a reminder of how much retirement capital sits on the wrong side of this move.
The Levels That Matter Into the Close
The technical structure is well defined and the numbers are tight. The S&P 500 closed Tuesday at 7,691.76 after gapping to roughly 7,700 — described as the low end of the recent range — and holding a 20-point band. Monday's close was 7,745.06. Friday's was 7,785.76. The record close is 7,798.99 from August 12, with the intraday all-time high at 7,816.70 set August 13. The 52-week range runs 6,316.91 to 7,816.70.
That gives a clean ladder. Reclaiming 7,745 puts Friday's 7,785 in play. Reclaiming 7,785 puts the record back in reach. Losing 7,691 opens the gap toward 7,600 with nothing structural in between. S&P futures at 7,748.75 in the premarket already sit above the first level, which means the open was a test of whether the reclaim holds through the auction and the minutes.
The Nasdaq Composite at 26,289.71 sits 513 points below the 26,803.03 close from August 12. Nasdaq-100 futures at 29,743.75 recovered part of Tuesday's 388-point decline. The Dow at 53,343.40 is 496 points below the 53,839.99 print from August 12 and holding better than either growth index — consistent with the defensive rotation into Johnson & Johnson, IBM and Chevron.
The VIX at 15.44 is the number that argues this is orderly. Three straight down days, a 19-year high in the long bond, a 5% drop in the KOSPI, and volatility is sitting at 15 after briefly climbing off 2026 lows. Hedging demand picked up Tuesday with a 3.75% VIX gain, but nothing in the volatility surface is pricing dislocation. September is historically the weakest month on Wall Street, and positioning has not yet adjusted for it.
The verdict: this is a duration repricing, not an earnings break, and it resolves at the long end rather than in the equity market. With S&P 500 profits growing 50% year over year and the index down three sessions, the constraint is the 5.31% thirty-year, not corporate performance. A 20-year auction that clears without tailing and minutes that isolate the three dissenters put 7,785 back in play by Friday's expiration. A tailed auction and evidence that the hawkish bloc was broader than 9–3 suggests takes out 7,691 and sends the market into Jackson Hole hunting for the next support shelf near 7,600.